Global Journal of Medical Research, F: Diseases, Volume 23 Issue 2

The characterization of inflammatory markers was described in Table 2 in detail to allow identification of the sample amplitude, as shown in Figure 1. Table 2: Characterization of the laboratory parameters of the population studied in Barreiras, Bahia, Brazil, 2020 Mean±SD Median Percentiles Minimum Maximum 25 75 Hemoglobin (g/ dL ) 14.17 ± 1.69 14 12.70 15.25 11.10 18.80 Hematocrit (%) 42.63 ± 4.63 41.90 39.40 45.30 32.90 52.60 Creatinine (mg/ dL ) 0.91 ± 0.25 0.89 0.73 1.08 0.42 1.44 Urea (mg/ dL ) 29.3 ± 7.65 29.00 23 34 14 51 Neutrophil/Lymphocyte Ratio 1.67 ± 0.65 1.60 1.18 2.07 0.38 3.13 IL-6 ( pg / mL ) 2.61 ± 1.17 2.24 1.53 3.56 1.35 6.10 Ferritin ( ng / mL ) 173.11 ± 99.92 154 99.65 207 27.40 400 D Vitamin ( ng / mL ) 26.18 ± 6.58 25.50 21.75 29.70 13.60 42.30 CRP (mg/L) 0.28 ± 0.29 0.15 0.06 0.45 0.02 1.19 Standard Deviation (SD); interleukin 6 (IL-6); C-reactive protein (CRP); 31 Year 2023 Global Journal of Medical Research Volume XXIII Issue II Version I ( D ) F © 2023 Global Journals Inflammatory Markers and Risk Factors in Hypertensive Patients: A Cross-Sectional Study BMI (Kg/m 2 ) 27±5 Sex Male 27 (44.3%) Female 34 (55.7%) Ethnicity Caucasian 6 (9.8%) Black 55 (90.2%) Education None 8 (13.1%) Literate 4 (6.6%) incomplete 1st grade 20 (32.8%) complete 1st degree 10 (16.4%) incomplete high school 3 (4.9%) complete high school 9 (14.8%) Incomplete higher 3 (4.9%) Graduated 4 (6.6%) Consumption of alcohol Yes 12 (19.7%) No 49 (80.3%) Hypertensive therapy None 2 (3.3%) Use one medication 19 (31.1%) Use two medications 20 (32.8%) Use three medications 11 (18%) Use more than three medications 9 (14.8%) Use of drugs Yes 1 (1.6%) No 60 (98.4%) Chronic kidney disease Yes 4 (6.6%) No 57 (93.4%)